Molecular Endocrinology, Vol 8, 374-381, Copyright © 1994 by Endocrine Society

ARTICLES

An alternatively spliced form of Pit-1 represses prolactin gene expression

RN Day and KH Day
Department of Medicine, University of Virginia, Charlottesville 22908.

The pituitary-specific transcription factor Pit-1 is required for expression of the PRL gene. Transcription of the PRL gene in the anterior pituitary is both activated and repressed in response to neuroendocrine signals. The molecular events that mediate repression are unknown. Transplantation of GH3 pituitary tumor cells from culture to female Wistar-Furth rats resulted in repression of PRL gene expression. When the transplanted cells were returned to culture, PRL gene expression was rapidly activated. We used this model to study potential mechanisms by which PRL gene expression was silenced. In addition to the appropriate size Pit-1 proteins of 33 and 31 kilodaltons, smaller forms of the transcription factor, migrating at approximately 27 and 24 kilodaltons, were found in transplanted cells in which PRL gene expression was repressed. These smaller forms of Pit- 1 protein were observed to disappear when transplanted cells were returned to culture, coincident with the activation of PRL gene expression. A transcript approximately 170 base pairs shorter than expected for that encoding full-length Pit-1 was detected in transplanted GH3 cell RNA by polymerase chain reaction. The shorter Pit- 1 transcript was abundant only in GH3 cells after in vivo passage and was not readily detected in transplanted cells after as little as 12 h in culture. This shorter transcript was found to result from excision of sequence corresponding to exon IV and encodes a Pit-1 protein lacking 54 amino acids of the POU-specific domain. Gene transfer studies demonstrated this alternative form of Pit-1 inhibited PRL promoter activity.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				G. A. Horwitz, I. Miklovsky, A. P. Heaney, S.-G. Ren, and S. Melmed Human Pituitary Tumor-Transforming Gene (PTTG1) Motif Suppresses Prolactin Expression Mol. Endocrinol., April 1, 2003; 17(4): 600 - 609. [Abstract] [Full Text] [PDF]

				J. F. Enwright III, M. A. Kawecki-Crook, T. C. Voss, F. Schaufele, and R. N. Day A PIT-1 Homeodomain Mutant Blocks the Intranuclear Recruitment Of the CCAAT/Enhancer Binding Protein {alpha} Required for Prolactin Gene Transcription Mol. Endocrinol., February 1, 2003; 17(2): 209 - 222. [Abstract] [Full Text] [PDF]

				C. J. Cox, H. M. Espinoza, B. McWilliams, K. Chappell, L. Morton, T. A. Hjalt, E. V. Semina, and B. A. Amendt Differential Regulation of Gene Expression by PITX2 Isoforms J. Biol. Chem., July 5, 2002; 277(28): 25001 - 25010. [Abstract] [Full Text] [PDF]

				B. Andersen and M. G. Rosenfeld POU Domain Factors in the Neuroendocrine System: Lessons from Developmental Biology Provide Insights into Human Disease Endocr. Rev., February 1, 2001; 22(1): 2 - 35. [Abstract] [Full Text]

				H. Baumeister, M. Wegner, D. Richter, and W. Meyerhof Dual Regulation Of Somatostatin Receptor Subtype 1 Gene Expression By Pit-1 In Anterior Pituitary GH3 Cells Mol. Endocrinol., February 1, 2000; 14(2): 255 - 271. [Abstract] [Full Text]

				J. T. Schanke, C. M. Conwell, M. Durning, J. M. Fisher, and T. G. Golos Pit-1/Growth Hormone Factor 1 Splice Variant Expression in the Rhesus Monkey Pituitary Gland and the Rhesus and Human Placenta J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 800 - 807. [Abstract] [Full Text] [PDF]

				E. Sock, J. Enderich, M. G. Rosenfeld, and M. Wegner Identification of the Nuclear Localization Signal of the POU Domain Protein Tst-1/Oct6 J. Biol. Chem., July 19, 1996; 271(29): 17512 - 17518. [Abstract] [Full Text] [PDF]

				W Herr and M A Cleary The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes & Dev., July 15, 1995; 9(14): 1679 - 1693. [PDF]